Dr Donald Kalff has lived and worked in the United States, the United Kingdom and continental Europe during the last 30 years. He gained a PhD from Wharton Business School, held management positions at the Royal Dutch/Shell Group and served on the Executive Board of KLM, Royal Dutch Airlines. Today he is co-founder and CEO of Immpact, a biotech company, advisor to biotech investment company BTF and strategy consultants Roland Berger.
